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D
PRWe studied the influence of arthritis on descending modulation of nociception from thehypothalamic paraventricular nucleus (PVN) in the rat. Spinal nociception was assessed by
the heat-evoked limb withdrawal in awake animals while neuronal responses were
recorded in a potential brainstem relay, the rostroventromedial medulla (RVM), under
pentobarbitone anesthesia. Following injection into the PVN, glutamate attenuated and
lidocaine enhanced nociceptive spinal reflex responses in arthritic and control animals. In
controls, PVN-induced antinociception was reversed by spinal administration of a 5-HT1A
receptor or an α2-adrenoceptor antagonist but not by an opioid receptor antagonist. In
arthritic animals, PVN-induced antinociception was not reversed by a 5-HT1A receptor
antagonist, while the roles of α2-adrenoceptors or opioid receptors could not be assessed
due to significant actions of antagonists alone. The spontaneous activity of presumably
pronociceptive ON-cells of the RVM and that of antinociceptive OFF-cells was increased in
arthritis. Lidocaine in the PVN increased ON-cell firing in control animals and decreased
OFF-cell firing in arthritic animals, while glutamate failed to affect activity of RVM cells. The
results indicate that the PVN influences phasic and tonic descending antinociception in
arthritic as well as control conditions, and the RVM may contribute to the relay of this
influence. In arthritis, the neurochemistry of descending antinociception differs at least
partly from that in controls. Arthritis has a dual influence on the PVN-induced drive of relay
cells in the RVM which reduces the arthritis-induced net change in the descending
antinociceptive influence from the PVN.
© 2007 Elsevier B.V. All rights reserved.Keywords:
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C1. Introduction
The paraventricular nucleus (PVN) of the hypothalamus is
involved in descending modulation of nociception. This is
indicated by the finding that electrical or chemical stimulation
of the PVN has produced spinal antinociception (Condés-Lara
et al., 2006; Miranda-Cardenas et al., 2006; Shiraishi et al., 1995;
Wang et al., 1990a; Yang et al., 2006; Yirmiya et al., 1990). In.
i.fi (A. Pertovaara).
s of the hypothalamus; R
er B.V. All rights reserved
F., et al., Influence of a
amus, Brain Res. (2008),5line with this, lesions of the PVN facilitated nociception (Yang
5et al., 2006) and attenuated stress-induced analgesia (Truesdell
5and Bodnar, 1987), although not in all experimental conditions
5(Fuchs and Melzack, 1996; Lariviere et al., 1995). Efferent con-
5nections to the spinal dorsal horn directly or indirectly through
5various relay nuclei in the brainstem, such as the periaque-
5ductal gray and the raphe magnus, provide a potential ana-
5tomical substrate for the descending antinociceptive actionVM, rostroventromedial medulla; WDR, wide-dynamic range
.
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ARTICLE IN PRESSinduced by the PVN (Holstege, 1987; Swanson and Sawchenko,
1983).
The role of various descending pathways and the neuro-
chemistry underlying PVN-induced antinociception is only
partly known. Early studies suggested that spinal antinocicep-
tion induced by PVN stimulation is not dependent on opioid
receptors or vasopressin (Shiraishi et al., 1995; Yirmiya et al.,
1990). More recent studies, however, suggest that opioid
receptors have a minor contribution to the PVN-induced anti-
nociception (Yang et al., 2006; Miranda-Cardenas et al., 2006),
while vasopressin (Yang et al., 2006) or oxytocin (Condés-Lara
et al., 2006; Miranda-Cardenas et al., 2006) play a major role in
mediating the descending antinociceptive action from the
PVN. This is in linewith a substantial number of hypothalamo-
spinal cells that are stained with antisera directed against
vasopressin or oxytocin (Cechetto and Saper, 1988; Condés-
Lara et al., 2007; Swanson and Sawchenko, 1983). Recent re-
sults indicate that activation of GABAergic spinal interneurons
by oxytocin may be involved in mediating the PVN-induced
antinociception at the spinal cord level (Rojas-Piloni et al.,
2007). Although the PVN-induced descending antinociception
may be explained by direct hypothalamo-spinal connections,
the potential role of various brainstem nuclei inmediating the
antinociceptive action from the PVN to the spinal cord still
remains to be studied. Concerning potential brainstem relay
nuclei and neurotransmitters mediating their action, it is notUN
CO
RR
EC
Fig. 1 – Mean latencies of heat-evoked limb withdrawal respons
(Lido) into the hypothalamic paraventricular nucleus (PVN) of con
was applied to the hind paw that was ipsilateral to the inflamed
lidocaine alone. B) Attempted reversal of glutamate-induced effe
naloxone (+Nx), and the effect of spinal administration of naloxo
effect by spinal administration of anα2-adrenoceptor antagonist,
atipamezole alone (Ati). D) Attempted reversal of glutamate-indu
antagonist, WAY-100635 (+Way), and the effect by spinal admini
S.E.M. (n=5–7). Unless specified otherwise, the asterisks indicate d
or Sal-group). *P<0.05, **P<0.01, ***P<0.005 (within groups: Dunn
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yet known whether the PVN-induced spinal antinociceptive
action involves monoaminergic neurotransmitters, such as
serotonin (5-HT) or norepinephrine, that are known to have an
important role in descending modulation of nociception (Per-
tovaara, 2006; Yaksh, 2006).
Pathophysiological conditionsmayinducesignificantchanges
in the function of descending pain-modulatory pathways lead-
ing to facilitation or attenuationof nociception (Pertovaara and
Almeida, 2006; Vanegas and Schaible, 2004). In experimental
arthritis, for example, the descending inhibition of afferent
barrage from the inflamed joint was enhanced (Schaible et al.,
1991). While it is known that arthritis is associated with
changes in the expressionof neuropeptides in the PVN (Shanks
et al., 1998), it is not known whether the modulation of noci-
ception descending from the PVN is changed in arthritis.
In the present investigation, we studied whether modula-
tion of spinal nociception by the PVN is changed in arthritis.
Also, we studied whether neurons in the rostroventromedial
medulla (RVM), a final common pathway formany descending
pathways (Gebhart, 2004), might have a role in mediating de-
scendingmodulation of nociception from the PVNof control or
arthritic animals. Furthermore, we assessed the roles of spinal
noradrenergic α2, serotoninergic 5-HT1A and opioidergic recep-
tors in mediating the descending modulation of nociception
from the PVNby intrathecalmicroinjections of selective recep-
tor antagonists in control and arthritic animals.TE
D
es following administration of glutamate (Glu) or lidocaine
trol (Ctrl) or arthritic (Arth) animals. The noxious test stimulus
knee joint in arthritic animals. A) Influence of glutamate or
ct by spinal administration of an opioid receptor antagonist,
ne alone (Nx). C) Attempted reversal of glutamate-induced
atipamezole (+Ati), and the effect by spinal administration of
ced effect by spinal administration of a 5-HT1A receptor
stration ofWAY-100635 alone (Way). The error bars represent
ifferenceswithin groups (reference: the corresponding saline
ett's test; between groups: t-test).
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Fig. 2 – Response properties of ON- and OFF-cells of the RVM in control (Ctrl) and arthritic (Arth) animals. A) Spontaneous
discharge rate. B) Response to noxious heating of the hind paw skin (ipsilateral to the inflamed knee joint in arthritic animals).
C) Response to noxious pinch of the tail. D) Response to noxious visceral stimulation (colorectal distension). The error bars
represent S.E.M. (n=14–23 in arthritic groups and n=22–34 in control groups). *P<0.05, **P<0.01, ***P<0.005 (t-test).
Fig. 3 – Mean spontaneous discharge rates of ON- and OFF-cells of the RVM in control (Ctrl) and arthritic (Arth) animals
following microinjection of glutamate or lidocaine into the hypothalamic paraventricular nucleus (PVN). A) Effect of glutamate
on discharge rate of ON-cells (nCtrl=18, nArth=11). B) Effect of glutamate on discharge rate of OFF-cells (nCtrl=9, nArth=6). C) Effect
of lidocaine on discharge rate of ON-cells (nCtrl=8, nArth=8). D) Effect of lidocaine on discharge rate of OFF-cells (nCtrl=4, nArth=5).
The error bars represent S.E.M. The Y-axis shows the time elapsed from the microinjection of glutamate or lidocaine.
Pre = before injection. *P<0.05 (Dunnett's test; Reference: the corresponding pre-injection rate).
3B R A I N R E S E A R C H X X ( 2 0 0 8 ) X X X – X X X
ARTICLE IN PRESS
Please cite this article as: Pinto-Ribeiro, F., et al., Influence of arthritis on descending modulation of nociception from the
paraventricular nucleus of the hypothalamus, Brain Res. (2008), doi:10.1016/j.brainres.2007.12.038
C111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168 Q1
169 Q2
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
4 B R A I N R E S E A R C H X X ( 2 0 0 8 ) X X X – X X X
ARTICLE IN PRESSRR
E
2. Results
2.1. Behavioral characterization of arthritis
All animals in the arthritic group developed a clear swelling of
the treated knee joint and all of them gave a vocalization
response to aminor extension and flexion of the affected limb
by the experimenter, whereas untreated control animals had
no obvious swelling in the knee joint and they did not vocalize
when the limb was moved.
2.2. Behavioral assessment of spinal antinociception
induced by the PVN
Behaviorally, spinal nociception was assessed by determining
the latency of the limb withdrawal response evoked by nox-
ious heating of the hind paw. Saline, glutamate (50 nmol) or
lidocaine (4%/0.5 μl) was microinjected into the PVN to study
the phasic and tonic regulation of spinal nociception in arth-
ritic animals versus controls. Administration of these com-
pounds in the PVN had a significant effect on the heat-evoked
hind-limb withdrawal latency (F2,26=45.3, P<0.0001): when
compared with saline, glutamate induced a significant pro-
longation (antinociception) and lidocaine a decrease (pronoci-
ception) of thewithdrawal latency (Fig. 1 A). Thesemodulatory
effects by glutamate or lidocaine in the PVN were not signi-
ficantly different between arthritic and control animals (F1,26=
0.14).
Naloxone (5.0 μg) was administered intrathecally to study
the potential contribution of spinal opioid receptors to the anti-
nociceptive action induced by glutamate in the PVN. Intrathecal
administration of naloxone did not attenuate the antinocicep-
tive effect induced by glutamate in the PVN of arthritic or con-
trol animals (Fig. 1 B). Intrathecal administration of naloxone
alone had no effect in controls but it increased the withdrawal
latency in arthritic animals.
Atipamezole, an α2-adrenoceptor antagonist (5.0 μg), was
administered intrathecally to study the involvement of spinal
α2-adrenoceptors in the antinociceptive action induced by
administration of glutamate in the PVN. In control animals,
atipamezole reversed the antinociceptive action of glutamate
in the PVN, while atipamezole alone had no significant effect
(Fig. 1 C). In arthritic animals, in contrast, atipamezole did notUN
CO
Fig. 4 – Mean changes in spontaneous discharge rates (A) and n
wide-dynamic range (WDR) neurons following injection of glutam
nucleus (PVN) in control (Ctrl) and arthritic (Arth) animals. 100%
bars represent S.E.M. (nSal=5, nGlu=7). *P<0.05, ***P<0.005 (t-test)
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influence the glutamate-induced antinociception, whereas ati-
pamezole alone induced a significant prolongation of thewith-
drawal latency (Fig. 1 C).
To study the role of spinal 5-HT1A receptors in antinocicep-
tion induced by glutamate in the PVN, WAY-100635 (3.0 μg), a
5-HT1A receptor antagonist, was administered intrathecally. In
control but not arthritic animals the antinociceptive action
induced by glutamate in the PVN was reversed by intrathecal
administration of WAY-100635. When administered alone,
WAY-100635 had no significant influence on the limb with-
drawal latency in arthritic or control animals (Fig. 1 D).
2.3. Response characteristics of ON- and OFF-cells of the
RVM
The RVM provides a potential link for mediating the pain-
regulatory effect from the PVN to the spinal dorsal horn. In
this study, we focused on assessing response properties of the
presumably pronociceptive ON-cells and antinociceptive OFF-
cells in the RVM. The number of RVM cells tested quantita-
tively was 49 (23 ON- and 14 OFF-cells) in arthritic animals and
68 (34 ON- and 22 OFF-cells) in controls. The receptive fields of
ON- and OFF-cells were typically wide covering all extremities
and the whole body. The distribution in the number of ON-
and OFF-cells was not significantly different between arthritic
and control animals (Fisher’s exact test).
2.4. Spontaneous discharge rate of RVM cells
The spontaneous discharge rate of ON- and OFF-cells in
the RVM was significantly increased by arthritis (F1,187=32.6,
P<0.0001; Fig. 2 A). The spontaneous discharge rate of OFF-
cells was significantly higher than that of ON-cells (F1,187=17.2,
P<0.0001), and this difference was significantly larger in ar-
thritic animals (F1,187=9.5, P<0.003).
2.5. Peripherally evoked responses of RVM cells
When assessing the peripherally evoked response of ON- and
OFF-cells, thenoxious stimuliwereapplied to thenon-inflamed
areadistal to thearthritic knee joint (heat), the tail (pinch) or the
viscera. The magnitude of the excitatory ON-cell response
evoked by noxious heating of the hind paw skin was not
significantly different between arthritic and control animals,oxious heat-evoked responses (B) of spinal dorsal horn
ate (Glu) or saline (Sal) into the hypothalamic paraventricular
represents the corresponding pre-injection value. The error
.
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Fig. 6 – Responses of a spinal dorsal horn WDR neuron to
noxious heat stimulation of the hind paw in an arthritic
animal before PVN injections (A), 30 s after injection of saline
in the PVN (B), and 30 s after injection of glutamate in the
PVN (C). i: neuronal response, ii: heat stimulus that starts
from the baseline temperature of 35 °C and reaches the peak
temperature of 54 °C. Vertical calibration bar for the trace i
represents 50 Hz, and the horizontal one 25 s.
Fig. 5 – Responses of a spinal dorsal horn WDR neuron to
noxious heat stimulation of the hind paw in a control animal
before PVN injections (A), 30 s after injection of saline in the
PVN (B), and 30 s after injection of glutamate in the PVN (C).
i: neuronal response, ii: heat stimulus that starts from the
baseline temperature of 35 °C and reaches the peak
temperature of 54 °C. Vertical calibration bar for i represents
50 Hz and the horizontal one 25 s.
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Cwhereas the magnitude of the inhibitory OFF-cell response
evoked by noxious heating was reduced in arthritis (Fig. 2 B).
The magnitudes of the ON- and OFF-cell responses evoked by
noxious tail pinchwere reduced in arthritic animals (Fig. 2 C). In
contrast, the magnitudes of colorectal distension-induced
responses of ON- and OFF-cells were slightly but significantly
increased in arthritis (Fig. 2 D).
2.6. Effects of glutamate or lidocaine administration in the
PVN on discharge rates of RVM cells
The spontaneous discharge rate of ON- and OFF-cells of the
RVM was assessed following microinjection of glutamate orPlease cite this article as: Pinto-Ribeiro, F., et al., Influence of a
paraventricular nucleus of the hypothalamus, Brain Res. (2008),1lidocaine in the PVN to study arthritis-induced changes in
2descending modulation of nociception originating in the PVN
2and relaying through the RVM. Glutamate in the PVN had no
2significant influence on the discharge rate of ON-cells in
2arthritic animals (F2,32=0.5) or controls (F2,53=0.6; Fig. 3 A).
2Neither did glutamate in the PVN influence the spontaneous
2discharge rate of OFF-cells in arthritic (F2,26=0.5) or control
2animals (F2,17=2.1; Fig. 3 B).
2Lidocaine in the RVM had no influence on the discharge
2rate of ON-cells in arthritic animals (F4,39=1), whereas it in-
2creased ON-cell activity in controls (F4,39=3.9, P<0.02; Fig. 3 C).
2Following lidocaine administration in the PVN, OFF-cell acti-
2vity was decreased in arthritic animals (F4,24=5.0, P<0.01), but
2not changed in controls (F4,19=1.2; Fig. 3 C).rthritis on descending modulation of nociception from the
doi:10.1016/j.brainres.2007.12.038
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Fig. 9 – A photographic example of a recording site in the
medulla (marked with an asterisk). Gi: gigantocellular
nucleus, GiA: alpha part of Gi, RMg: raphe magnus nucleus,
ml: medial lemniscus.
Fig. 7 – A photographic example of a microinjection site in
the hypothalamus. Pa: paraventricular nucleus, PaV: ventral
part of Pa, PaLM: lateral magnocellular part of Pa, PaDC:
dorsal cap of Pa, PaMP: medial parvocellular part of Pa.
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ARTICLE IN PRESS2.7. Spinal dorsal horn WDR neurons
Effect of glutamate in the PVN on spinal dorsal horn WDR
neurons was determined to exclude the possibility that the
PVN-inducedmodulationof spinal nociceptive reflex responses
was rather due to suppression of spinal motor than sensory
responses.Whilearthritis producedasignificant increase in theUN
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Fig. 8 – Microinjection sites in the PVN. The anteroposterior
distance from the interaural line is 7.28 mm for section A,
7.20 mm for section B, and 7.09 mm for section C. Each
symbol represents cannula locations in one to four animals.
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OObaseline spontaneous discharge rate of WDR neurons (P<0.05,t-test), glutamate in the PVN failed to produce a significantsuppressionof the spontaneous discharge rate ofWDRneurons(F1,20=2.02; Fig. 4 A), independent of the experimental group
(F1,20=0.73). Heat-evoked responses of spinal dorsal horn WDR
neurons were significantly decreased by glutamate in the PVN
when compared with the effect of saline (F1,20=9.8, P<0.001;
Figs. 4 B, 5 and 6), and this glutamate-induced spinal antino-
ciceptive effectwas not significantly different between arthritic
and control animals (F1,20=0.05).
2.8. Injection and recording sites
Figs. 7 and 8 show microinjection sites in the PVN, and Figs. 9
and 10 show recording sites in the RVM. Based on the esti-
mated spread of the currently used injection volume of 0.5 μl
(Myers, 1966), the injections spread both to the magno- and
parvocellular areas of the PVN and areas immediately adja-
cent to the PVN. The recording sites in the RVM were in the
raphe magnus and the adjacent medial bulboreticular forma-
tion. In the spinal dorsal horn, recording sites were in the deep
spinal dorsal horn as assessed from the depth of recording
sites from the cord surface (400–1000 μm).241
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2563. Discussion
3.1. Influence of arthritis on the PVN-induced spinal
antinociception and a potential relay in the RVM
Glutamate in the hypothalamic paraventricular nucleus (PVN)
suppressed and lidocaine in the PVN facilitated noxious heat-
evoked spinal withdrawal responses in arthritic and control
animals. This finding indicates that the PVNhas a role in phasic
and tonic suppression of spinal nociception in arthritic as well
as control conditions. It isnoteworthy that glutamate in thePVN
suppressed not only a spinal withdrawal reflex but also the
response of presumed pain-relay neurons in the spinal dorsal
horn indicating that the PVN induced rather a true antinocicep-
tive action than only a suppression of the motor expression of
nociception.Moreover, thepresent results indicate that arthritis
induces changes in firing rates of presumed pain-modulatory
cells in the rostroventromedial medulla (RVM), a structure thatrthritis on descending modulation of nociception from the
doi:10.1016/j.brainres.2007.12.038
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Fig. 10 – Recording sites marked with electrolytic lesions in the RVM. The anteroposterior distance from the interaural line is
1.92 mm for section A, 2.04 mm for section B, 2.16 mm for section C, 2.40 mm for section D and 2.64 mm for section E. Each
symbol represents recording sites of one to five neurons.
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receives efferent projections from the PVN (Holstege, 1987) and
that is known to be an important relay for descending mo-
dulation of spinal nociception (Gebhart, 2004). Interestingly,
arthritis-induced changes in spontaneous firing rates of prono-
ciceptive ON- and antinociceptive OFF-cells of the RVM were
likely to have opposite effects on spinal antinociception. This is
indicated by the finding that the spontaneous activity of both
pronociceptive ON-cells and antinociceptive OFF-cells was in-
creased in arthritis. The concurrent promotion of descending
pro- and antinociceptive influence from the RVM of arthritic
animals may contribute to the observations that the baseline
nociception of arthritic animals outside of the inflamed region,
as indicated by the withdrawal response to heating of the hind
paw distal to the inflamed joint, was not significantly different
from that in controls. Previous results indicate that during the
first hours, inflammation leads to enhanced descending facil-
itation from the RVM whereas during a later phase the net
descending effect from the RVM is inhibition (Terayama et al.,
2000). This finding suggests that the pronociceptive influence of
arthritis might have been stronger in the present study if the
experiments had been performed within the first few hours,
instead of several days after induction of arthritis. It should also
be noted that the currently used injection volume of 0.5 μl may
have spread to areas adjacent to the target area in the PVN and
therefore, the present results do not allow excluding the pos-
sibility that brain areas adjacent to the PVN contribute to the
present findings.
Glutamate in the PVN failed to influence discharge rates of
RVM cells in arthritic or control animals. This finding suggests
that the RVM may not have a critical role in mediating phasic
antinociception induced by PVN-stimulation. On the other
hand, lidocaine in the PVN increased firing rates of pronoci-
ceptive ON-cells in control animals and decreased firing of
antinociceptive OFF-cells in arthritic animals. This finding
suggests that the PVN in a tonic and dissociative fashiondrives
the RVM and that the drive is changed by arthritis. The net
descending effect of the PVN-induced tonic drive need not,
however, be changed by arthritis, since the PVN-induced tonic
suppression of pronociceptive RVM ON-cells in control ani-
mals may have an equal effect on spinal nociception as the
PVN-induced tonic facilitation of antinociceptive RVM OFF-
cells. In linewith thisproposal, the behavioral results indicatedPlease cite this article as: Pinto-Ribeiro, F., et al., Influence of a
paraventricular nucleus of the hypothalamus, Brain Res. (2008),TE
D
PR
OO 2that lidocaine in the PVN had an equal spinal pronociceptive 3effect in arthritic and control animals. These findings are in 3linewith the hypothesis that the RVM is involved inmediating
3tonic PVN-induced modulation of spinal nociception.
3The magnitudes of pinch- and heat-evoked responses of
3RVM cells were decreased in arthritis. It should be noted,
3however, that in this study pinch and heat were applied to the
3skin area outside of the inflamed joint. Therefore, sustained
3nociceptive barrage from the inflamed joint may have atte-
3nuated concurrent nociceptive signals evoked by pinch and
3heat stimulation of the healthy skin area. In line with this
3proposal, this type of a phenomenon that is also called diffuse
3noxious inhibitory controls (Le Bars et al., 1979) is known to be
3effective in arthritis (Calvino et al., 1987). Although the RVM is
3not involved in mediating diffuse noxious inhibitory controls
3(Bouhassira et al., 1993), the RVM receives ascending nocicep-
3tive signals from the spinal dorsal horn, a structure that is
3influenced by diffuse noxious inhibitory controls (Le Bars
3et al., 1979). Responses to noxious visceral stimulation, in
3contrast, were slightly enhanced in arthritis. Possibly the con-
3verging cutaneous receptive fields of spinal neurons mediat-
3ing visceral nociception from the colorectal area are large
3enough to receive and summate sustained nociceptive signals
3from the inflamed joint which might explain enhanced vis-
3ceral responses.
3Previous studies have shown that a number of pathophy-
3siological models such as prolonged noxious thermal stimu-
3lation, opioid withdrawal, mustard oil-induced neurogenic
3inflammation and spared nerve injury model of neuropathy
3produce hypersensitivity that is associated with increased
3activity of pronociceptive ON-cells in the RVM (Bederson et al.,
31990; Gonçalves et al., 2007; Kincaid et al., 2006; Morgan and
3Fields, 1994; Xu et al., 2007) and that may, in some conditions,
3be accompaniedby a decreased activity of antinociceptiveOFF-
3cells (Gonçalves et al., 2007). In the present study, arthritis
3increased activity of both pro- and antinociceptive RVM cells.
3Arthritis failed to produce a significant change in the limb
3withdrawal evoked by heating the paw distal to the inflamed
3joint; thiswas expectedbasedon thearthritis-induced changes
3in discharge properties of RVM cells. Together, the results are
3in line with the hypothesis that ON- and OFF-cells of the RVM
3have a role in modulation of spinal nociception in variousrthritis on descending modulation of nociception from the
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pathophysiological as well as control conditions (Fields et al.,
2006), although themagnitude of contribution and the pattern
of firing rate changesmay vary depending on the experimental
condition.
3.2. Spinal neurotransmitter receptors involved in the
PVN-induced antinociception
In control animals, antinociception inducedbyglutamate in the
PVNwas reversed by spinal administration of a 5-HT1A receptor
antagonist and an α2-adrenoceptor antagonist, whereas the
effect of an opioid receptor antagonist on the PVN-induced
antinociception was not significant. This finding indicates that
underphysiological conditions serotoninergic raphe-spinal and
descending noradrenergic pathways acting on spinal 5-HT1A
and α2-adrenoceptors, respectively, are involved in mediating
the PVN-induced spinal antinociceptive action. This is in line
with previous results indicating that the PVN has efferent
connections to various pain-modulatory nuclei in the brain-
stem, including the serotoninergic raphe magnus (Holstege,
1987; Swanson and Sawchenko, 1983) and that electrical or
chemical stimulationof theRVMmay inhibitnociceptiondue to
action on spinal 5-HT1A receptors (el-Yassir and Fleetwood-
Walker, 1990; Wei and Pertovaara, 2006). Efferent connections
from the PVN directly to the noradrenergic locus coeruleus in
the pons (Swanson and Sawchenko, 1983) provide a link for
activation of descending noradrenergic pathways that contri-
bute to thePVN-inducedantinociceptiondue toactiononspinal
α2-adrenoceptors. Additionally, the PVNmight recruit descend-
ing noradrenergic pathways through the RVM (Nuseir et al.,
1999; Sim and Joseph, 1992). In line with earlier findings (Shi-
raishi et al., 1995; Yirmiya et al., 1990), the present results sug-
gest that spinal opioid receptors donot have a critical role in the
PVN-induced antinociception in control animals.
Unlike under control conditions, the contribution of spinal
5-HT1A receptors to the PVN-induced antinociception was not
significant inarthritic animals. Thus, arthritis inducedachange
in the contribution of the serotoninergic system to the PVN-
induced antinociception. While spinal administration of an
α2-adrenoceptor or opioid receptor antagonist alone had no
significant effect on pain-related behavior in control animals,
these compounds produced a significantmodulatory action in
inflamed animals. Paradoxically, the changes produced by an
α2-adrenoceptor or opioid receptor antagonist alone were pro-
longations of the limb withdrawal latency. A plausible expla-
nation for the paradoxically increased withdrawal latency by
the receptor antagonists alone is removal of arthritis-induced
noradrenergic and opioidergic feedback inhibition (Pertovaara,
2006; Yaksh, 2006) and a consequent increase in the sustained
nociceptive barrage fromthe inflamed joint that led to a central
suppression of heat-evoked responses from the cutaneous test
site in thehindpaw; i.e., spinally administeredα2-adrenoceptor
and opioid receptor antagonistsmay have enhanced sustained
jointpainandconsequently, diffusenoxious inhibitory controls
(Calvino et al., 1987) that suppressed concurrent nociception
elsewhere. Due to significant actions by the α2-adrenoceptor
and opioid receptor antagonists alone, the present results do
not allow concluding whether the contribution of spinal nora-
drenergic or opioid receptors to the PVN-induced antinocicep-
tive effect is changed in arthritis.Please cite this article as: Pinto-Ribeiro, F., et al., Influence of a
paraventricular nucleus of the hypothalamus, Brain Res. (2008),TE
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3.3. Spinal neurotransmitters mediating descending
antinociception from the PVN versus other hypothalamic areas
Interestingly, while the present results indicate that spinal
5-HT1A receptors and α2-adrenoceptors are involved in med-
iating the descending antinociceptive effect from the PVN in
control conditions, earlier results indicate that these mono-
aminergic receptors mediate descending antinociception also
from the lateral hypothalamus (Holden and Naleway, 2001;
Holden et al., 2005). In contrast, while some earlier (Shiraishi
et al., 1995; Yirmiya et al., 1990) and the present results indicate
that spinal opioid receptors have only a minor, if any, role in
the PVN-induced antinociception, the spinal antinociceptive
effect induced by stimulation of the hypothalamic arcuate
nucleus was reversed by spinal administration of an opioid
receptor antagonist (Wang et al., 1990b).
3.4. Conclusions
The PVN has a phasic and tonic descending antinociceptive
influence in arthritic as well as control animals. The RVMmay
contribute to the relay of descending influence from the PVN.
Arthritis induced a dual change in the baseline activity and the
PVN-induced tonic drive of pro- and antinociceptive cells of
the RVM. Due to these dual arthritis-induced changes that
produced opposite actions, the net effect of RVM cells in the
control of baseline nociception or in the relay of tonic inhi-
bitory influence from the PVNmay remain the same, although
the roles of pro- and antinociceptive cells vary between the
arthritic and control conditions. Recent studies indicate that
vasopressin (Yang et al., 2006) or oxytocin (e.g., Condés-Lara
et al., 2006; Miranda-Cardenas et al., 2006) released from hy-
pothalamo-spinal neurons have an important role in the PVN-
induced antinociception. These findings indicate that direct
action by descending axons of hypothalamic neurons in the
spinal dorsal horn may alone be sufficient to induce anti-
nociception. The present results extend these findings by
showing that descending serotoninergic and noradrenergic
pathways acting on spinal 5-HT1A receptors and α2-adreno-
ceptors, respectively, may also contribute to the PVN-induced
inhibition of spinal nociception in control conditions.4. Experimental procedures
4.1. Animals, anesthesia and ethical issues
The experiments were performed in adult male Wistar Han
rats with 250–300 g (Harlan Netherlands, Horst, Netherlands).
The experimental protocol was approved by the Institutional
Ethical Commission and followed the European Community
Council Directive 86/609/EEC for the use of experimental ani-
mals. All efforts were made to minimize animal suffering and
to use only the number of animals necessary to produce reli-
able scientific data.
For the experimental surgery and electrophysiological ses-
sions, anesthesiawas inducedbyadministeringpentobarbitone
(50 mg/kg, i.p.) and the anesthesia was maintained by infusing
pentobarbitone (15–20 mg/kg/h, i.p.) when necessary. The level
of anesthesiawas frequentlymonitored by observing the size ofrthritis on descending modulation of nociception from the
doi:10.1016/j.brainres.2007.12.038
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the pupils, the generalmuscle tone and behavioral responses to
noxious pinching. Importantly, the anesthesia level was main-
tained in an identical fashion when studying control and
arthritic animals. Therefore, a potential influence of anesthesia
level, if any, was identical in control and arthritic groups. A
warming blanket was used to maintain the body temperature
within physiological range. At the completion of the experi-
ment, animals received a lethal dose of pentobarbitone.
4.2. Procedures for intrathecal and intracerebral
microinjections
For the insertion of the intrathecal cannula, a thin polyethy-
lene cannula (PE-10, Becton Dickinson & Co., Sparks, MD) was
inserted into the lumbar subarachnoid space as described in
detail elsewhere (Størkson et al., 1996). The intrathecally in-
serted catheter was then fixed through a layer of superficial
muscles, tunneled rostrally and made to appear through the
skin in the occipital region. Upon recovery from anesthesia,
10 μl of 2% lidocaine hydrochloride, followed by 10–15 μl of
saline was given through the catheter – with the help of a
50 μl-Hamilton microsyringe (Hamilton Inc., Reno, NV) – to
verify if it was indeed spinally located. Only rats that devel-
oped reversible symmetrical paralysis of both hind limbs and
tail after the injection of lidocaine were used in the experi-
ments. Intrathecal cannula was inserted at least one week
before actual experiments. Test-drugs were injected intrathe-
cally at a volume of 5 μl using a 50 μl-Hamilton microsyringe,
flushed afterwards with 10–15 μl of saline.
For intracerebral drug administration, the rats were placed
in a stereotaxic frame and a stainless steel guide cannula
(26 gauge; Plastics One, Roanoke, VA) was implanted in the
brain according to the coordinates of the atlas by Paxinos and
Watson (1998). The tip of the guide cannula was positioned
1 mm above the desired injection site in the PVN (AP, 7.2 mm;
LM, 0.2 mm; DV, 7.9 mm to the interaural line). After the guide
cannula was fixed into the skull using a dental screw and
dental cement, a dummy cannula was inserted into the guide
cannula and the top was closed. Animals were allowed to
recover from surgery for one week before testing.
Test-drugswereadministered in thePVN througha33-gauge
injection cannula (Plastics One) inserted into and protruding
1 mm beyond the tip of the guide cannula. The microinjection
was made using a 1.0-μl-Hamilton syringe connected to the
injection cannula by a polyethylene catheter (PE-10). The injec-
tion volume was 0.5 μl and therefore, the spread of the injected
drugs within the brain was at least 1 mm (Myers, 1966). The
efficacy of injection wasmonitored by watching themovement
of a small air bubble through the tubing.The injection lasted30s
and the injection cannulawas left in place for an additional 30 s
to minimize the return of drug solution back to the injection
cannula. Brain injection sites were histologically verified from
post-mortem sections and plotted on standardized sections
derived from the stereotaxic atlas of Paxinos andWatson (1998).
4.3. Induction of arthritis
The induction of arthritis was performed 7–14 days before the
actual experiments as described in detail elsewhere (Ansah
and Pertovaara, 2007). Briefly, 3% kaolin and 3% carrageenanPlease cite this article as: Pinto-Ribeiro, F., et al., Influence of a
paraventricular nucleus of the hypothalamus, Brain Res. (2008),TE
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5(Sigma, St. Louis, MO, USA) were dissolved in distilled water
5and injected into the synovial cavity of the left knee joint at a
5volume of 0.1 ml. This model produces mechanical hyper-
5algesia with the onset of a few hours and a duration of up to
58 weeks (Radhakrishnan et al., 2003). In each animal, devel-
5opment of arthritis was verified 1–2 h prior to each experi-
5ment. Only those rats that vocalized every time after five
5flexion–extension movements of the knee joint were consid-
5ered to have arthritis, and they were included in the arthritis
5group. Untreated control animals did not vocalize to any of the
5five consecutive flexion–extension movements of the knee
5joint.
54.4. Behavioral assessment of nociception
5The rats were habituated to the experimental conditions by
5allowing them to spend 1–2 h daily in the laboratory during two
5to threedaysprecedingany testing. For assessingnociception in
5unanesthetized animals, radiant heat-induced latency of paw
5withdrawal was determined using radiant heat equipment
5(Plantar Test Device Model 7370, Ugo Basile, Comerio, Italy) as
5described in detail earlier (Hargreaves et al., 1988). Radiant heat
5wasapplied to theplantar skin of thehind limb ipsilateral to the
5inflamed knee joint and the PVN injection. In each drug treat-
5ment session, the withdrawal latency was assessed prior to
5drug treatment and at various interval following the intracere-
5bral and intrathecal injections. At each time point, the mea-
5surement was repeated twice at an interval of 1 min and the
5mean of these values was used in further calculations. Cut-off
5time was 20 s. Since spinal transection does not abolish the
5heat-induced limbwithdrawal (e.g., Kauppila et al., 1998), it is a
5spinally organized nociceptive reflex, although it is modulated
5by brainstem–spinal pathways in intact animals. Therefore, the
5heat-induced limbwithdrawal provides amethod for determin-
5ing spinalnociceptionand its supraspinalmodulation inbehav-
5ing animals and also under anesthesia (e.g., Luukko et al., 1994).
54.5. Recording of neuronal responses in the
5rostroventromedial medulla (RVM)
5RVM neurons provide a potential relay for descending influ-
5ence from the RVM. Therefore, we studied the response pro-
5perties of RVM neurons and themodulation of their activity by
5the PVN in control and arthritic animals. For electrophysiolo-
5gical recordings ofneurons in theRVM, anesthesiawas induced
5and continued as described above, and the animal was placed
5in a standard stereotaxic frame according to the atlas of
5Paxinos and Watson (1998). The skull was exposed and a hole
5was drilled for placement of a recording electrode in the RVM.
5Thedesired recording site in theRVMwas 1.8–2.3mmposterior
5from the ear bar, 0.0–0.5 mm lateral from the midline, and 8.9–
510.7 mm ventral from the dura mater. Single neuron activity
5was recorded extracellularly with lacquer-coated tungsten
5electrodes (tip impedance 3–10MΩ at 1 kHz) and then amplified
5and filtered using standard techniques. Data sampling was
5performed with a computer connected to a CED Micro 1401
5interface and using Spike 2 software (Cambridge Electronic
5Design, Cambridge, U.K.).
5Actual recordings of RVM neurons did not start until the
5animal was under light anesthesia; i.e., the animals gave arthritis on descending modulation of nociception from the
doi:10.1016/j.brainres.2007.12.038
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ARTICLE IN PRESSbrief withdrawal response to noxious pinch, but the pinch did
not produce any longer lasting motor activity, nor did the
animals have spontaneous limb movements. RVM neurons
were classified based on their response to noxious heating
(54 °C) of the hind paw with a feedback-controlled Peltier
device (LTS-3 Stimulator, Thermal Devices Inc., Golden Valley,
MN; Wilcox and Giesler, 1984), as described below. For detec-
tion of a heat-evoked limb withdrawal concurrently with the
neuronal response, a piezoceramic movement detector (Sie-
mens Elema Ab., Medicinsk Teknik, Solna, Sweden) of low
weight (<0.5 g) was taped on the skin overlying the hamstring
muscle in the mid thigh level of the stimulated hind limb and
the movement of the limb measured with it as described
earlier (Hämäläinen et al., 1996). For classification of RVM
neurons, the scheme developed earlier (reviewed by Fields
et al., 2006) was adapted. Briefly, neurons giving an excitatory
heat-evoked response that was associated with a hind-limb
withdrawal were considered to be pronociceptive ON-cells,
those giving an inhibitory response that was associated with a
limb withdrawal were considered to be antinociceptive OFF-UN
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Fig. 11 – Examples of original recordings of RVM cells.
A) ON-cell in a control animal. B) OFF-cell in an arthritic
animal. In A, i shows the neuronal response, ii the
withdrawal response in the hind limb, and iii the noxious
heat stimulus applied to the hind paw. In B, i shows the
neuronal response, ii the noxious heat stimulus, and iii the
noxious visceral stimulus (colorectal distension). In both
graphs, P–P indicate the duration of the noxious tail pinch.
The vertical calibration bar for neuronal response represents
10 Hz in A and 20 Hz in B. In both graphs, the baseline
temperature of the heat stimulus is 35 °C and the peak
stimulus temperature 54 °C. In B, colorectal distension is
applied at an intensity of 80 mmHg. The horizontal
calibration bar represents 50 s in A and 40 s in B.
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cells (Fig. 11). Neurons showing no or only a negligible (<10%)
change in their discharge rates as a response to noxious sti-
mulation were considered to be NEUTRAL-cells which were
not studied further in this investigation. If a neuron could not
be classified it was not included in the study. Classification of
RVM neurons was not attempted unless the noxious test sti-
mulus induced a hind-limb withdrawal reflex.
Characterization of the response properties of an RVM cell
consisted of the following assessment performed succes-
sively: 1. Spontaneous activity. 2. Response to heating of the
hind paw ipsilateral to the treated knee with a Peltier device
(LTS-3 Stimulator; a heat ramp rising at the rate of 10 °C/s
from the baseline temperature of 35 °C to the peak tempe-
rature of 54 °C and peak duration of 10 s). 3. Response to
pinching of the tail for 5 s by a surgical clamp that produced
painful sensation when applied to the hand of the experi-
menter. 4. Response to colorectal distension (CRD) at a nox-
ious intensity (80 mmHg; Ness et al., 1991) and duration of
10 s. CRD was produced by inflating with air a 7–8 cm flexible
latex balloon inserted transanally into the descending colon
and rectum. The pressure in the balloon was controlled by an
electronic device (Anderson et al., 1987).
When analyzing responses of RVM neurons to peripheral
stimulation, the baseline discharge frequency recorded during
a corresponding period just before the stimulation was sub-
tracted from the discharge frequencies determined during sti-
mulation; i.e., positive values represent excitatory responses
evoked by peripheral stimulation and negative ones inhibitory
responses.
The animals used in recordings had a guide cannula for
drug administrations into the PVN. Electrophysiological expe-
riments were performed one to two weeks after fixation of the
guide cannula to the skull, as described above. After determin-
ing the responses of an RVM neuron to peripheral stimulation,
the phasicmodulation of the discharge rate of RVMneurons by
the PVNwas assessed bymicroinjecting glutamate (50 nmol in
0.5 μl) into the PVN using methods described above. The dis-
charge rate of the RVM cells was followed up to 5min after the
injection of glutamate. Thereafter, tonic control of the RVM by
the PVNwas assessed bymicroinjecting lidocaine (4% in 0.5 μl)
into the PVN and following the discharge rate of RVM neurons
up to 30 min.
4.6. Recording of neuronal responses in the spinal dorsal
horn
To exclude the possibility that the PVN-inducedmodulation of
spinal reflex responses is rather due to action on spinal motor
than sensory neurons, we determined the PVN-induced effect
on responses of wide-dynamic range (WDR) neurons of the
spinal dorsal horn. One to two weeks before the recordings of
spinal dorsal horn neurons, a chronic guide cannula was in-
serted to the PVN as described above. Following induction of
anesthesia with pentobarbitone (50 mg/kg i.p. followed by
15–25 mg/kg/h or more, if required according to continuous
observation of the anesthesia level), a laminectomy was per-
formed at the level of T12–L2 vertebrae. The durawas removed
and the spinal cord was covered with warm mineral oil. Two
spinal clamps, one rostral and one distal to the laminectomy,
were used to stabilize the preparation. Data samplingmethodsrthritis on descending modulation of nociception from the
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were the same as with the RVM recordings (see above). In the
spinal dorsal horn, searchand classificationof spinal unitswas
performed as described in detail elsewhere (Pertovaara et al.,
2001). Only wide-dynamic range (WDR) neurons activated by
innocuous stimulation (brush) and giving a differential re-
sponse to heat stimulation within nociceptive range (46–54 °C)
were studied further. All the WDR neurons included in the
study had their receptive fields in the plantar skin of the hind
paw. The recording depth from the spinal cord surface was
0.4–1.0 mm.
When assessing the PVN-induced modulation of the re-
sponse of a spinal dorsal horn neuron, the noxious test sti-
mulus was a heat ramp applied from a Peltier device (LTS-3
Stimulator). The stimulus started from the baseline tempera-
ture of 35 °C and ascended to the peak temperature of 54 °C at
a rate of 10 °C/s. The duration of the peak temperature was
10 s. The response to heat was determined 5 min prior to and
30 s after the injection of saline or glutamate (50 nmol in 0.5 μl)
into the PVN. The magnitude of the response before the injec-
tion was considered the reference response (100%) for each
neuron. The order of testing glutamate or saline was varied
between the neurons and the interval between testing the
effects of glutamate and saline on the same neuron was at
least 5 min. The interval between testing different neurons in
the same animal was at least 30 min.
4.7. Drugs
The opioid receptor antagonist naloxonehydrochloride and the
5-HT1A receptor antagonist WAY-100635 were purchased from
Sigma (St. Louis,MO,USA),while theα2-adrenoreceptor antago-
nist atipamezole was obtained from Orion Pharma Inc. (Turku,
Finland). The intrathecal doses of naloxone, WAY-100635 and
atipamezole were chosen based on our previous investigations
showing that at the dose range used these receptor antagonists
alone had no significant effects on nociception in control or
neuropathic animals (Pertovaara andWei, 2003, 2007;Wei and
Pertovaara, 2006). It should be noted that unlike many other
α2-adrenoreceptor antagonists, atipamezole does not bind to
5-HT1A receptors (Pertovaaraetal., 2005). Sodiumpentobarbitone,
glutamate and physiological saline were obtained from Orion
Pharma Inc. (Espoo, Finland), and the local anesthetic, lido-
caine, was obtained from Astra (Södertälje, Sweden).
4.8. Course of the behavioral study
One to two weeks following induction of the arthritis and at
least one week following insertion of the intrathecal catheter
and the guide cannula for PVN injections, the efficacy of PVN-
induced phasic and tonic modulation of spinal nociception
was determined by assessing the effect of glutamate and
lidocaine in the PVN on the heat-evoked spinal withdrawal
reflex in unanesthetized arthritic and control animals. Physio-
logical saline was used for control injections and untreated
animals were used as control animals. In these experiments,
the latency of the withdrawal response was assessed 30 s,
5 min, 15 min and 30 min following the injection. The latency
measured 30 s after glutamate injection and 15 min after
lidocaine injection was used in further calculations, since the
maximum effects of the studied compounds are obtained atPlease cite this article as: Pinto-Ribeiro, F., et al., Influence of a
paraventricular nucleus of the hypothalamus, Brain Res. (2008),TE
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6these time points. The interval between behavioral assess-
7ments of glutamate-, lidocaine- or saline-induced effects was
7at least two days and the order of testing different compounds
7was varied between the animals.
7Assessment of spinal neurotransmitter receptors mediat-
7ing the descending antinociceptive influence induced by gluta-
7mate in the PVNwas also assessed one to twoweeks following
7induction of arthritis. In these experiments, one of the three
7receptor antagonists studied (atipamezole, WAY-100635 or
7naloxone)was administered intrathecally immediately follow-
7ing the assessment of the pre-drug latency. The effect of the
7receptor antagonist alone on the withdrawal latency was
7assessed 10 min following its intrathecal administration. At
7this time point, all the studied receptor antagonists should
7have their maximum effects. Glutamate (50 nmol) was micro-
7injected into the PVN about 13 min following the intrathecal
7injectionof the receptor antagonist. To assesspossible reversal
7of the glutamate-induced antinociception by the spinally ad-
7ministered receptor antagonist, the heat-evoked withdrawal
7latency was again determined 30 s after injection of glutamate
7into the PVN; i.e., the potential reversal of PVN-induced anti-
7nociception was determined about 14–15 min following the
7intrathecal injection of the receptor antagonist. When testing
7different receptor antagonists in the same animal, the interval
7between testing sessions was at least two days. The order of
7testing different receptor antagonists was varied between the
7animals. Each animal participated in 1–3 behavioral testing
7sessions. At the end of the experiment, the animalswere given
7a lethal dose of pentobarbitone and the brains were removed
7for histological verification of the injections sites.
74.9. Course of the electrophysiological study
7Electrophysiological recordingsofRVMneuronsor spinal dorsal
7horn neurons were performed under pentobarbitone anesthe-
7sia in different animals one to two weeks following the induc-
7tion of arthritis and at least one week following the insertion of
7the guide cannula for PVN injections. In RVM recordings, the
7response properties of the neuronswere assessed by determin-
7ing spontaneousactivity and response tonoxiousheatingof the
7skin, tail pinch and CRD. Then, the change in spontaneous
7activity of RVM neurons following successive microinjections
7of glutamateand lidocaine at a 15min interval into thePVNwas
7assessed as described in detail above. Search for the next neu-
7ron to be studied started about 30 min after the testing of the
7previous one was completed. At the end of the recording ses-
7sion, electrolytic lesions were made in the recording sites, the
7animals were given a lethal dose of pentobarbitone and the
7brains were removed for histological verification of the record-
7ing and injection sites.
7In recordings of spinal dorsal hornWDR neurons, the heat-
7evoked response was determined before and 30 s after injec-
7tion of glutamate or saline into the PVN; i.e., testing was per-
7formed at the time point when glutamate has its maximum
7effect. The interval between testing the salineandglutamate in
7the same neuronswas at least 5min, and the interval between
7testing different neurons in the same animal was at least
715 min. At the end of the recording session, the animals were
7given a lethal dose of pentobarbitone and the brain removed
7for histological verification of the injection site.rthritis on descending modulation of nociception from the
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Two-way analysis of variance (ANOVA) followed by Dunnett's
test (comparisons between three or more groups) or t-test
(comparisons between two groups) were used in statistical
assessment of the data. The differences in the incidence of
various types of RVM neurons were analyzed using Fisher's
exact test. P<0.05 was considered to represent a significant
difference.827
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